Clinical Trials for Diabetes and Related-Conditions

Clinical Trials for Diabetes and Related-Conditions

 

The 439 clinical trials listed here include 298 that have not yet started recruiting patients or are just now seeking volunteers to participate and another 141 that are active, but not recruiting new patients. This information is potentially valuable to patients still seeking effective treatments for diabetes and diabetes-related conditions. It provides a new therapeutic option to discuss with physicians. Those interested in obtaining more information about certain trials can use the URL code listed for each test to log onto www.clinicaltrials.gov, the clinical tests database of the National Institutes of Health.

 

Study 1 – Active, not recruiting

 

Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

 

Type 1 Diabetes, Diabetic Neuropathy

 

http://ClinicalTrials.gov/show/NCT01293461

 

 

 

Study 2 -- Recruiting

 

Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01453751

 

 

 

Study 3 – Active, not recruiting

 

PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00690066

 

 

 

Study 4 -- Recruiting

 

Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01620489

 

 

 

Study 5 – Active, not recruiting

 

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01336023

 

 

 

Study 6 – Active, not recruiting

 

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00838903

 

 

 

Study 7 – Active, not recruiting

 

A Study in Adults With Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01421147

 

 

 

Study 8 – Active, not recruiting

 

NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01085292

 

 

 

Study 9 – Recruiting

 

A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01682902

 

 

 

Study 10 – Recruiting

 

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01617434

 

 

 

Study 11 – Not yet recruiting

 

Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01541215

 

 

 

Study 12 – Active, not recruiting

 

A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01569841

 

 

 

Study 13 – Recruiting

 

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00658021

 

 

 

Study 14 -- Recruiting

 

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01686945

 

 

 

Study 15 – Recruiting

 

A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01704417

 

 

 

Study 16 – recruiting

 

The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01664247

 

 

 

Study 17 – Active, not recruiting

 

A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01513590

 

 

 

Study 18 – Active, not recruiting

 

Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00940173

 

 

 

Study 19 – Recruiting

 

Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01206101

 

 

 

Study 20 – Recruiting

 

The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01618162

 

 

 

Study 21 -- Recruiting

 

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01676116

 

 

 

Study 22 – Recruiting

 

Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01680341

 

 

 

Study 23 – Recruiting

 

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01570751

 

 

 

Study 24 – Active, not recruiting

 

Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01512108

 

 

 

Study 25 – Active, not recruiting

 

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01513473

 

 

 

Study 26 – Recruiting

 

A Study in Patients With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01435616

 

 

 

Study 27 – Recruiting

 

Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01485614

 

 

 

Study 28 – Recruiting

 

Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00322478

 

 

 

Study 29 – Recruiting

 

Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00703599

 

 

 

Study 30 – Not yet recruiting

 

A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01713530

 

 

 

Study 31 – Recruiting

 

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00701935

 

 

 

Study 32 – Active, not recruiting

 

Safety and Efficacy of YH14617 in Diabetes Mellitus

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01507038

 

 

 

Study 33 – Active, not recruiting

 

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00660907

 

 

 

Study 34 – Active, not recruiting

 

Exenatide Versus Glimepiride in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00359762

 

 

 

Study 35 – Active, not recruiting

 

Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01003184

 

 

 

Study 36 – Recruiting

 

Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus

 

Type-2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01472614

 

 

 

Study 37 – Active, not recruiting

 

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01392677

 

 

 

Study 38 – Active, not recruiting

 

Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT00814294

 

 

 

Study 39 – Recruiting

 

Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01576328

 

 

 

Study 40 – Recruiting

 

Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00896077

 

 

 

Study 41 – Active, not recruiting

 

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01079325

 

 

 

Study 42 – Active, not recruiting

 

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01179048

 

 

 

Study 43 – Recruiting

 

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01204775

 

 

 

Study 44 – Not yet recruiting

 

Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01646320

 

 

 

Study 45 – Recruiting

 

Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01619059

 

 

 

Study 46 – Active, not recruiting

 

A Trial of 18F-AV-133 Positron Emission Tomography (PET)

 

Type 1 Diabetes, Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01515384

 

 

 

Study 47 – Recruiting

 

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01606007

 

 

 

Study 48 – Active, Not recruiting

 

Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01377844

 

 

 

Study 49 – Not yet recruiting

 

Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01710371

 

 

 

Study 50 – Recruiting

 

Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)

 

Type 2 Diabetes, Cardiovascular Disease

 

http://ClinicalTrials.gov/show/NCT01394952

 

 

 

Study 51 – Active, not recruiting

 

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01095666

 

 

 

Study 52 – Recruiting

 

CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01243424

 

 

 

Study 53 – Recruiting

 

Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations

 

Type 1 Diabetes, Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01680328

 

 

 

Study 54 – Active, not recruiting

 

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00663260

 

 

 

Study 55 – Recruiting

 

A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01195662

 

 

 

Study 56 – Recruiting

 

A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01137474

 

 

 

Study 57 – Active, not recruiting

 

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01167881

 

 

 

Study 58 – Recruiting

 

Finding a Safe and Effective Dose of Linagliptin in Peadiatric Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01342484

 

 

 

Study 59 – Recruiting

 

A Study in Patients With Type I Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01454284

 

 

 

Study 60 – Recruiting

 

BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01131676

 

 

 

Study 61 – Recruiting

 

A Study in Participants With Type 1 Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01481779

 

 

 

Study 62 – Recruiting

 

A Study in Participants With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01468987

 

 

 

Study 63 – Recruiting

 

A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01582451

 

 

 

Study 64 – Active, not recruiting

 

Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01289990

 

 

 

Study 65 – Active, not recruiting

 

Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01304537

 

 

 

Study 66 – Active, not recruiting

 

Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus

 

Type 2 Diabetes, Obesity

 

http://ClinicalTrials.gov/show/NCT01306214

 

 


 

 

Study 67 – Recruiting

 

Stem Cell Educator Therapy in Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01350219

 

 

 

Study 68 – Recruiting

 

Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01596504

 

 

 

Study 69 – Active, not recruiting

 

Efficacy and Safety of BI 10773/BI 1356 Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01422876

 

 

 

Study 70 – Recruiting

 

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01498185

 

 

 

Study 71 – Active, not recruiting

 

Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01123083

 

 

 

Study 72 – Active, not recruiting

 

A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00894322

 

 

 

Study 73 – Active, not recruiting

 

Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00998699

 

 

 

Study 74 – Recruiting

 

Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

 

Adolescent Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01554618

 

 

 

Study 75 – Recruiting

 

Single Ascending Dose Trial in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01492465

 

 

 

Study 76 – Recruiting

 

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01144338

 

 

 

Study 77 – Recruiting

 

Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome

 

Type 2 Diabetes, Acute Coronary Syndrome

 

http://ClinicalTrials.gov/show/NCT00968708

 

 

 

Study 78 – Recruiting

 

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002 AM1)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01640873

 

 

 

Study 79 – Recruiting

 

A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria

 

Type 2 Diabetes, Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT01440257

 

 

 

Study 80 – Recruiting

 

Pharmacokinetics, Pharmacodynamics and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00957268

 

 

 

Study 81 – Active, not recruiting

 

Long-term Study of KAD-1229 in Type 2 Diabetes Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01333592

 

 

 

Study 82 – Active, not recruiting

 

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01289119

 

 

 

Study 83 – Active, not recruiting

 

Safety and Efficacy of Albiglutide in Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00849056

 

 

 

Study 84 – Active, not recruiting

 

Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00849017

 

 

 

Study 85 – Recruiting

 

Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device

 

Type 1 Diabetes, Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00889668

 

 

 

Study 86 – Active, not recruiting

 

A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00838916

 

 

 

Study 87 – Active, not recruiting

 

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01474538

 

 

 

Study 88 – Recruiting

 

Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01497522

 

 

 

Study 89 – Recruiting

 

Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes

 

Hypertension, Diabetes

 

http://ClinicalTrials.gov/show/NCT01496430

 

 

 

Study 90 – Active, not recruiting

 

Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis

 

Diabeteic Gastroparesis

 

http://ClinicalTrials.gov/show/NCT01452815

 

 

 

Study 91 – Recruiting

 

A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01624259

 

 

 

Study 92 – Active, not recruiting

 

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 1 Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01194245

 

 

 

Study 93 – Active, not recruiting

 

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01194258

 

 

 

Study 94 – Not yet recruiting

 

Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01652729

 

 

 

Study 95 – Recruiting

 

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01495013

 

 

 

Study 96 – Not yet recruiting

 

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

 

Type 2 Diabetes, Hyperlipidemia

 

http://ClinicalTrials.gov/show/NCT01673178

 

 

 

Study 97 – Active, not recruiting

 

A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01106651

 

 

 

Study 98 – Not yet recruiting

 

Stem Cell Therapy for Type 1 Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01143168

 

 

 

Study 99 – Active, not recruiting

 

Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01357252

 

 

 

Study 100 – Not yet recruiting

 

Stem Cell Therapy for Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01142050

 

 

 

Study 101 – Active, not recruiting

 

Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Subjects With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00856284

 

 

 

Study 102 – Recruiting

 

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01103284

 

 

 

Study 103 – Active, not recruiting

 

A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01381900

 

 

 

Study 104 – Recruiting

 

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01699737

 

 

 

Study 105 – Active, not recruiting

 

A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01672762

 

 

 

Study 106 – Recruiting

 

A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01674348

 

 

 

Study 107 – Recruiting

 

Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01475461

 

 

 

Study 108 – Recruiting

 

Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01472185

 

 

 

Study 109 – Recruiting

 

A Phase III Study to Evaluate Safety, Tolerability and Efficacy of CureXcell™ in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes Mellitus

 

Lower Extremity Chronic Diabetic Ulcers

 

http://ClinicalTrials.gov/show/NCT01421966

 

 

 

Study 110 – Recruiting

 

Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01494987

 

 

 

Study 111 – Not yet recruiting

 

Safety and Efficacy of Exenatide Injection in Subjects With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01406717

 

 

 

Study 112 – Recruiting

 

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

 

Diabetic Gastroparesis

 

http://ClinicalTrials.gov/show/NCT01394055

 

 

 

Study 113 – Active, not recruiting

 

A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00836940

 

 

 

Study 114 – Active, not recruiting

 

Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints

 

Type 2 Diabetes, Cardiovascular Disease

 

http://ClinicalTrials.gov/show/NCT00549757

 

 

 

Study 115 – Recruiting

 

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01645332

 

 

 

Study 116 – Active, not recruiting

 

A Study in Patients With Type 2 Diabetes Mellitus (AWARD-4)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01191268

 

 

 

Study 117 – Recruiting

 

A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01682759

 

 

 

Study 118 – Active, not recruiting

 

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01240759

 

 

 

Study119 – Recruiting

 

Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis

 

Diabetic Gastroparesis

 

http://ClinicalTrials.gov/show/NCT01571297

 

 

 

Study 120 – Active, not recruiting

 

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Patients With Type 2 Diabetes Mellitus (0431-251 AM2)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01189890

 

 

 

Study 121 – Active, not recruiting

 

Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis

 

Diabetic Gastroparesis

 

http://ClinicalTrials.gov/show/NCT00845858

 

 

 

Study 122 – Recruiting

 

Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01582230

 

 

 

Study123 – Active, not recruiting

 

Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130 AM1)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01177384

 

 

 

Study 124 – Active, not recruiting

 

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus (RISE)

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT00473330

 

 

 

Study 125 – Active, not recruiting

 

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus (RIDE)

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT00473382

 

 

 

Study 126 – Recruiting

 

Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 Diabetics

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01645696

 

 

 

Study 127 – Not yet recruiting

 

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01455857

 

 

 

Study 128 – Recruiting

 

A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes

 

Type 2 Diabetes, Hyperlipidemia

 

http://ClinicalTrials.gov/show/NCT01607294

 

 

 

Study 129 – Not yet recruiting

 

A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01455909

 

 

 

Study 130 – Not yet recruiting

 

A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01455883

 

 

 

Study 131 – Recruiting

 

MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01517321

 

 

 

Study 132 – Not yet recruiting

 

A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01455922

 

 

 

Study 133 – Not yet recruiting

 

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01455870

 

 

 

Study 134 – Recruiting

 

Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01647308

 

 

 

Study 135 – Not yet recruiting

 

A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01455896

 

 

 

Study 136 – recruiting

 

Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01664624

 

 

 

Study 137 – Active, not recruiting

 

A Study of OPC-262 in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01193179

 

 

 

Study 138 – Active, not recruiting

 

Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00615264

 

 

 

Study 139 – Recruiting

 

Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01456195

 

 

 

Study 140 – Active, not recruiting

 

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease

 

Type 2 Diabetes, Cardiovascular Disease

 

http://ClinicalTrials.gov/show/NCT01042977

 

 

 

Study 141 – Recruiting

 

Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01481116

 

 

 

Study 142 – Recruiting

 

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease

 

Type 2 Diabetes, Cardiovascular Disease

 

http://ClinicalTrials.gov/show/NCT01609582

 

 

 

Study 143 – Recruiting

 

Comparison of Technosphere Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01451398

 

 

 

Study 144 – Recruiting

 

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

 

Type 2 Diabetes, Chronic Kidney Disease

 

http://ClinicalTrials.gov/show/NCT01621178

 

 

 

Study 145 – Active, not recruiting

 

Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01194882

 

 

 

Study 146 – Not yet recruiting

 

Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01652716

 

 

 

Study 147 – Recruiting

 

A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01370707

 

 

 

Study 148 – Recruiting

 

Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01452451

 

 

 

Study 149 – Active, not recruiting

 

A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01043029

 

 

 

Study 150 – Recruiting

 

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01459809

 

 

 

Study 151 – Active, not recruiting

 

Safety Study of Subcutaneously Injected Prandial INSULIN-PH20 NP Compared to Insulin Analog Injection in Patients With Type 1 Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00883558

 

 

 

Study 152 – Recruiting

 

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

 

Obstructive Pulmonary Disease in Diabetes

 

http://ClinicalTrials.gov/show/NCT00642616

 

 

 

Study 153 – Active, not recruiting

 

A Study in Patients With Type 2 Diabetes Mellitus (AWARD-2)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01075282

 

 

 

Study 154 – Recruiting

 

A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01042769

 

 

 

Study 155 – Active, not recruiting

 

A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01376323

 

 

 

Study 156 – Active, not recruiting

 

Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Type 2 Diabetics

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00703612

 

 

 

Study 157 – Active, not recruiting

 

Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01301833

 

 

 

Study 158 – Active, not recruiting

 

Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01414920

 

 

 

Study 159 – Recruiting

 

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01597713

 

 

 

Study 160 – Recruiting

 

Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01690169

 

 

 

Study 161 – Recruiting

 

A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01691755

 

 

 

Study 162 – Recruiting

 

Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01572649

 

 

 

Study 163 – Recruiting

 

Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01517373

 

 

 

Study 164 – Not yet recruiting

 

Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01647542

 

 

 

Study 165 – Recruiting

 

A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01472367

 

 

 

Study 166 – Recruiting

 

A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01680978

 

 

 

Study 167 – Active, not recruiting

 

Welchol as Monotherapy for Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00789737

 

 

 

Study 168 – Recruiting

 

A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01665352

 

 

 

Study 169 – Not yet recruiting

 

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01649297

 

 

 

Study 170 – Recruiting

 

Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01544881

 

 

 

Study 171 – Not yet recruiting

 

Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01316861

 

 

 

Study 172 – Recruiting

 

Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination Compared to Glimepiride in Patients With Type 2 Diabetes Mellitus (0431A-202 AM1)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00993187

 

 

 

Study 173 – Recruiting

 

A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01644500

 

 

 

Study 174 – Not yet recruiting

 

A Study Designed to Compare 2 Formulations of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00662857

 

 

 

Study 175 – Recruiting

 

NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria

 

Type 2 Diabetes, Albuminuria

 

http://ClinicalTrials.gov/show/NCT01547897

 

 

 

Study 176 – Recruiting

 

Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01614769

 

 

 

Study 177 – Active, not recruiting

 

Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01387737

 

 

 

Study 178 – Active, not recruiting

 

Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00789750

 

 

 

Study 179 – Recruiting

 

A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of the SGLT-2 Inhibitor Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01248364

 

 

 

Study 180 – Recruiting

 

A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01648582

 

 

 

Study 181 – Active, not recruiting

 

A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01514838

 

 

 

Study 182 – Active, not recruiting

 

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00482950

 

 

 

Study 183 – Recruiting

 

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01555164

 

 

 

Study 184 – Recruiting

 

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01658579

 

 

 

Study 185 – Recruiting

 

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

 

Type 2 Diabetes, Renal Impairment

 

http://ClinicalTrials.gov/show/NCT01555008

 

 

 

Study 186 – Recruiting

 

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01035801

 

 

 

Study 187 – Recruiting

 

A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01557504

 

 

 

Study 188 – Active, not recruiting

 

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01505426

 

 

 

Study 189 – Active, not recruiting

 

A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01582308

 

 

 

Study 190 – Recruiting

 

A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01703208

 

 

 

Study 191 – Recruiting

 

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01683266

 

 

 

Study 192 – Active, not recruiting

 

Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00995540

 

 

 

Study 193 – Recruiting

 

A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211 AM1)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01477853

 

 

 

Study 194 – Active, not recruiting

 

A Dose-Range Finding Study in Patient With Type 2 Diabetes (MK-3102-006 EXT1(AM3))

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01217073

 

 

 

Study 195 – Active, not recruiting

 

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01499082

 

 

 

Study 196 – Not yet recruiting

 

Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01632163

 

 

 

Study 197 – Recruiting

 

Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01445951

 

 

 

Study 198 – Recruiting

 

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01499095

 

 

 

Study 199 – Active, not recruiting

 

Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01353469

 

 

 

Study 200 – Recruiting

 

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01676220

 

 

 

Study 201 – Recruiting

 

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

 

Type 2 Diabetes, Cardiovascular Disease, Obesity, Dyslipidemia

 

http://ClinicalTrials.gov/show/NCT01474161

 

 

 

Study 202 – Recruiting

 

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01223131

 

 

 

Study 203 – Recruiting

 

Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM3)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01462266

 

 

 

Study 204 – Recruiting

 

A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002 AM1)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01614782

 

 

 

Study 205 – Recruiting

 

A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019 AM1)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01698775

 

 

 

Study 206 – Not yet recruiting

 

Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01704261

 

 

 

Study 207 – Not yet recruiting

 

A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01702298

 

 

 

Study 208 – Not yet recruiting

 

A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01678820

 

 

 

Study 209 – Enrolling by invitation

 

Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00644501

 

 

 

Study 210 – Active, not recruiting

 

A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00839527

 

 

 

Study 211 -- Recruiting

 

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01069965

 

 

 

Study 212 – Recruiting

 

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01619332

 

 

 

Study 213 – active, not recruiting

 

CANVAS - CANagliflozin cardioVascular Assessment Study

 

Type 2 Diabetes Mellitus, Cardiovascular Disease

 

http://ClinicalTrials.gov/show/NCT01032629

 

 

 

Study 214 – Active, not recruiting

 

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00968812

 

 

 

Study 215 – Active, not recruiting

 

Randomized, Double-blind, Crossover, PK and GD Study of CSII in Subjects With Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01275131

 

 

 

Study 216 – Recruiting

 

AMG 151 Amgen Protocol Number 20100761

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01464437

 

 

 

Study 217 – Not yet recruiting

 

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01708044

 

 

 

Study 218 – Active, not recruiting

 

Naturlose (D-Tagatose) Efficacy Evaluation Trial

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00955747

 

 

 

Study 219 – Active, not recruiting

 

30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01183013

 

 

 

Study 220 – Active, not recruiting

 

A Clinical Study to Evaluate the Effect of Naturlose (Tagatose)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00961662

 

 

 

Study 221 – Active, not recruiting

 

Subcutaneous Administration of Otelixizumab to T1DM Patients

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00946257

 

 

 

Study 222 – Recruiting

 

Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01496339

 

 

 

Study 223 – Active, not recruiting

 

A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01316107

 

 

 

Study 224 – Active, not recruiting

 

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01242202

 

 

 

Study 225 – Active, not recruiting

 

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01242228

 

 

 

Study 226 – Active, not recruiting

 

Reparixin in Pancreatic Islet Transplantation

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01220856

 

 

 

Study 227 – Recruiting

 

PK Study of Dapagliflozin in Pediatric Subjects With T2DM

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01525238

 

 

 

Study 228 – Active, not recruiting

 

Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT01629199

 

 


 

 

Study 229 – Recruiting

 

Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in Type1 Diabetes

 

Type1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01357603

 

 

 

Study 230 – Not yet recruiting

 

Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01525225

 

 

 

Study 231 – Recruiting

 

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

 

Type 2 Diabetes, Chronic Kidney Disease

 

http://ClinicalTrials.gov/show/NCT01487109

 

 

 

Study 232 – Active, not recruiting

 

A Study of RO6807952 in Patients With Diabetes Mellitus Type 2

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01358929

 

 

 

Study 233 – Active, not recruiting

 

A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01398267

 

 

 

Study 234 – Recruiting

 

A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01691846

 

 

 

Study 235 – Not yet recruiting

 

A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01691989

 

 

 

Study 236 – Recruiting

 

A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01529528

 

 

 

Study 237 – Recruiting

 

Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01529541

 

 

 

Study 238 – Recruiting

 

The Effects of LY2409021 on the Liver

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01588366

 

 

 

Study 239 – Active, not recruiting

 

Pharmacokinetics/Pharmacodynamics of Albiglutide

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01357889

 

 

 

Study 240 – Recruiting

 

Long-term Study of SYR-472

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01431807

 

 

 

Study 241 – Recruiting

 

Clinical Trial to Evaluate the Efficacy and Safety of the Use of Ozone Versus Sunflower Oil in Treating Diabetic Foot

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01643967

 

 

 

Study 242 – recruiting

 

A Study of LY2605541 Versus Insulin Glargine on Blood Sugar

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01654380

 

 

 

Study 243 – Recruiting

 

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01245166

 

 

 

Study 244 – Recruiting

 

Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01699932

 

 

 

Study 245 – Active, not recruiting

 

Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00790205

 

 

 

Study 246 – Active, not recruiting

 

A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01316094

 

 

 

Study 247 – Recruiting

 

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01686620

 

 

 

Study 248 – Recruiting

 

Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01106131

 

 

 

Study 249 – Recruiting

 

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01658501

 

 

 

Study 250 – Active, not recruiting

 

ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT00525577

 

 

 

Study 251 – Not yet recruiting

 

Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01559025

 

 

 

Study 252 – Recruiting

 

Study of Combination Therapy With SYR-322

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01521962

 

 

 

Study 253 – Recruiting

 

Long-term Study of SYR-322

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01456130

 

 

 

Study 254 – Recruiting

 

Reversing Type 1 Diabetes After it is Established

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01106157

 

 

 

Study 255 – Not yet recruiting

 

A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

 

Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT01712061

 

 

 

Study 256 – recruiting

 

Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)

 

Gestational Diabetes

 

http://ClinicalTrials.gov/show/NCT01234649

 

 

 

Study 257 – Recruiting

 

A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01065948

 

 

 

Study 258 – Recruiting

 

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy

 

Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT01447147

 

 

 

Study 259 – Not yet recruiting

 

Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analog Glargine in Type 1 Diabetic Patients

 

Type I Diabetes

 

http://ClinicalTrials.gov/show/NCT01352663

 

 

 

Study 260 – Not yet recruiting

 

Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics

 

Type I Diabetes

 

http://ClinicalTrials.gov/show/NCT01398670

 

 

 

Study 261 – Not yet recruiting

 

Metformin Glycinate on Metabolic Control and Inflammatory Mediators in DM2 Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01386671

 

 

 

Study 262 – Recruiting

 

Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01140893

 

 

 

Study 263 – Recruiting

 

Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00315133

 

 

 

Study 264 – Recruiting

 

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

 

Type I Diabetes

 

http://ClinicalTrials.gov/show/NCT01308437

 

 

 

Study 265 – Recruiting

 

Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01497938

 

 

 

Study 266 – Recruiting

 

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01551381

 

 

 

Study 267 – Not yet recruiting

 

Safety and Effectiveness Study of a Closed Loop System Maintaining Patients' Glucose Levels During an Overnight Period

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01712594

 

 

 

Study 268 – Recruiting

 

Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients

 

Type 2 Diabetes, Prediabetes, Atherosclerosis

 

http://ClinicalTrials.gov/show/NCT00995930

 

 

 

Study 269 – Recruiting

 

Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

 

End Stage Renal Disease, Diabetes

 

http://ClinicalTrials.gov/show/NCT00755404

 

 

 

Study 270 – Recruiting

 

The CareFUL Prevention Trial

 

Plantar Ulcer, Diabetes

 

http://ClinicalTrials.gov/show/NCT00803608

 

 

 

Study 271 – Recruiting

 

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral ZYGK1 in Healthy Volunteers

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01472809

 

 

 

Study 272 – Not yet recruiting

 

A Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Fenofibrate Versus Placebo on Macular Thickness and Volume

 

Type 1 Diabetes, Diabetic Retinopathy, Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT01320345

 

 

 

Study 273 – Active, not recruiting

 

Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes

 

Obesity

 

http://ClinicalTrials.gov/show/NCT01272232

 

 

 

Study 274 – Recruiting

 

Statins in Children With Type 1 Diabetes and Hypercholesterolemia

 

Diabetes, Hypercholesterolemia

 

http://ClinicalTrials.gov/show/NCT01236365

 

 

 

Study 275 – Enrolling by invitation

 

Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes(LADA)

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01159847

 

 

 

Study 276 – Recruiting

 

Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00451620

 

 

 

Study 277 – Recruiting

 

Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01628445

 

 

 

Study 278 – Active, not recruiting

 

UVA Islet Cell Transplantation in Patients With Type I Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00605592

 

 

 

Study 279 – Recruiting

 

Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes

 

Diabetes, Postprandial Lipemia

 

http://ClinicalTrials.gov/show/NCT00660075

 

 

 

Study 280 – Active, not recruiting

 

Actos Now for Prevention of Diabetes (ACT NOW)

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00220961

 

 

 

Study 281 – recruiting

 

Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01393808

 

 

 

Study 282 – Not yet recruiting

 

Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01666028

 

 

 

Study 283 – Not yet recruiting

 

Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01661192

 

 

 

Study 284 – recruiting

 

Effects of Metreleptin in Type 1 Diabetes Mellitus

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01268644

 

 

 

Study 285 – Active, not recruiting

 

Clinical Trail of Tang-min-Ling Pills in Type 2 Diabetes Mellitus

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01087242

 

 

 

Study 286 – recruiting

 

REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01483560

 

 

 

Study 287 – Recruiting

 

Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01334229

 

 

 

Study 288 – Recruiting

 

The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children

 

Type I Diabetes

 

http://ClinicalTrials.gov/show/NCT00875290

 

 

 

Study 289 – Active, not recruiting

 

Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

 

Type 2 Diabetes 

 

http://ClinicalTrials.gov/show/NCT01137695

 

 

 

Study 290 – Not yet recruiting

 

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

 

Diabetic Peripheral Neuropathy

 

http://ClinicalTrials.gov/show/NCT01681290

 

 

 

Study 291 – Active, not recruiting

 

A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01104701

 

 

 

Study 292 – Recruiting

 

Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01708902

 

 

 

Study 293 – Not yet recruiting

 

Mechanistic Pilot Trial to Evaluate Endothelial Impact of Linagliptin in Type 2 Diabetic Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01703286

 

 

 

Study 294 – Not yet recruiting

 

The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)

 

Maturity-onset Diabetes of the Young

 

http://ClinicalTrials.gov/show/NCT01610934

 

 

 

Study 295 – Not yet recruiting

 

Metformin and Sitagliptin in Women With Previous Gestational Diabetes

 

Prediabetes

 

http://ClinicalTrials.gov/show/NCT01336322

 

 

 

Study 296 – Recruiting

 

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01581476

 

 

 

Study 297 – Recruiting

 

Comparison of Effects of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes

 

Type 2 Diabetes, Heart Failure

 

http://ClinicalTrials.gov/show/NCT01586442

 

 

 

Study 298 – Not yet recruiting

 

Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes

 

Gestational Diabetes

 

http://ClinicalTrials.gov/show/NCT01662921

 

 

 

Study 299 – Active, not recruiting

 

Acetyl-L-Carnitine in Type 2 Diabetes

 

Type 2 Diabetes, Hypertension

 

http://ClinicalTrials.gov/show/NCT00984750

 

 

 

Study 300 – Active, not recruiting

 

Study Assessing the PK of EFB0027 and Effect on Circulating Glucose and GI Hormone Concentrations in Subjects With T2DM

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01677299

 

 

 

Study 301 – Recruiting

 

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

 

Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT01200394

 

 


 

 

Study 302 – Active, not recruiting

 

Randomised Trial of Health Coaching in Secondary Prevention of Diabetes and Heart Disease

 

Type 2 Diabetes, Heart Failure, Coronary Disease

 

http://ClinicalTrials.gov/show/NCT00552903

 

 

 

Study 303 – Recruiting

 

Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01662999

 

 

 

Study 304 – Recruiting

 

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01192711

 

 

 

Study 305 – Recruiting

 

Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01549964

 

 

 

Study 306 – Recruiting

 

Exenatide in Type 2 Diabetes on Insulin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01154933

 

 

 

Study 307 – Active, not recruiting

 

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01478399

 

 

 

Study 308 – Active, not recruiting

 

TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00179777

 

 

 

Study 309 – Not yet recruiting

 

A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus

 

Macular Edema after Cataract Surgery in Patients With Diabetes Mellitus

 

http://ClinicalTrials.gov/show/NCT01673191

 

 

 

Study 310 – Active, not recruiting

 

VEGF Trap-Eye in Vision Impairment Due to DME

 

Diabetes, Macular Edema

 

http://ClinicalTrials.gov/show/NCT01331681

 

 

 

Study 311 – Active, not recruiting

 

Nutritional Prevention Pilot Trial for Type 1 Diabetes

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00570102

 

 

 

Study 312 – Recruiting

 

LIraglutide and Beta-cell RepAir (LIBRA) Study

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01270789

 

 

 

Study 313 – Recruiting

 

Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT00330265

 

 

 

Study 314 – recruiting

 

Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01452113

 

 

 

Study 315 – Not yet recruiting

 

A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics

 

Type 2 Diabetes, Obesity

 

http://ClinicalTrials.gov/show/NCT01644201

 

 

 

Study 316 – Recruiting

 

Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01517412

 

 

 

Study 317 – Active, not recruiting

 

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01476475

 

 

 

Study 318 – Recruiting

 

Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients on Oral Antidiabetic Medication

 

Type 2 Diabetes, Iron Deficiency Anemia

 

http://ClinicalTrials.gov/show/NCT01513369

 

 

 

Study 319 – Not yet recruiting

 

Study to Evaluate the Efficacy of Acarbose, Metformin, Sitagliptin Combination Treatment in DM Patients

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01490918

 

 

 

Study 320 – Recruiting

 

Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)

 

Cystic Fibrosis Related Diabetes

 

http://ClinicalTrials.gov/show/NCT00639626

 

 

 

Study 321 – recruiting

 

Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus

 

Erectile Dysfunction in Diabetes

 

http://ClinicalTrials.gov/show/NCT00705861

 

 

 

Study 322 – recruiting

 

Long-term Study of TAK-875

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01433406

 

 

 

Study 323 – Recruiting

 

Double-blind Comparative Study of SYR-472

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01632007

 

 

 

Study 324 – Recruiting

 

Open-label Study of TAK-875

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01433419

 

 

 

Study 325 – Not yet recruiting

 

Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT00426920

 

 

 

Study 326 – Not yet recruiting

 

Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01648153

 

 

 

Study 327 – Active, not recruiting

 

Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01156779

 

 

 

Study 328 – Recruiting

 

Double-blind Comparative Study of TAK-875

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01433393

 

 

 

Study 329 – Recruiting

 

Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01554293

 

 

 

Study 330 – Recruiting

 

Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage

 

Diabetic Vitreous Hemorrhage

 

http://ClinicalTrials.gov/show/NCT01030770

 

 

 

Study 331 – Active, not recruiting

 

European Trial of Immunosuppression in SPK Tx

 

Type 1 Diabetes, Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT00140543

 

 

 

Study 332 – Recruiting

 

A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

 

Type 2 Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT01488877

 

 

 

Study 333 – Active, not recruiting

 

New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I

 

Type 2 Diabetes, Obesity

 

http://ClinicalTrials.gov/show/NCT00566189

 

 

 

Study 334 – Recruiting

 

Caspase Inhibition in Islet Transplantation

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01653899

 

 

 

Study 335 – Recruiting

 

Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes

 

Gestational Diabetes

 

http://ClinicalTrials.gov/show/NCT00850135

 

 

 

Study 336 – Recruiting

 

Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

 

Diabetes-Related Fatty Liver, Lipid Metabolism

 

http://ClinicalTrials.gov/show/NCT00529204

 

 

 

Study 337 – Recruiting

 

DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study)

 

Gestational Diabetes, Obesity

 

http://ClinicalTrials.gov/show/NCT00865683

 

 

 

Study 338 – Recruiting

 

Sitagliptin in the Elderly

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00451113

 

 

 

Study 339 – Recruiting

 

Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00609154

 

 

 

Study 340 – Active, not recruiting

 

Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients

 

Diabetes, Coronary Stenosis

 

http://ClinicalTrials.gov/show/NCT00462631

 

 

 

Study 341 – Active, not recruiting

 

PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

 

Diabetes, Coronary Artery Disease

 

http://ClinicalTrials.gov/show/NCT00116792

 

 

 

Study 342 – Active, not recruiting

 

Rosiglitazone Plaque Study

 

Type 2 Diabetes, Hypertension

 

http://ClinicalTrials.gov/show/NCT00123227

 

 

 

Study 343 – Recruiting

 

Comparison of Lantus and NPH Insulin in the Dawn Phenomenon

 

Type 1 Diabetes, Dawn Phenomenon

 

http://ClinicalTrials.gov/show/NCT00694122

 

 

 

Study 344 – Active, not recruiting

 

Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT00533442

 

 

 

Study 345 – Recruiting

 

Insulin Resistance Intervention After Stroke Trial

 

Diabetes, Stroke, Myocardial Infarction

 

http://ClinicalTrials.gov/show/NCT00091949

 

 

 

Study 346 – Recruiting

 

Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers

 

Chronic Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT00366132

 

 

 

Study 347 – Not yet recruiting

 

Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00975533

 

 

 

Study 348 – Active, not recruiting

 

Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE

 

Diabetes, Cardiovascular Disease

 

http://ClinicalTrials.gov/show/NCT00461630

 

 

 

Study 349 – Active, not recruiting

 

Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT01171976

 

 

 

Study 350 – Active, not recruiting

 

Insulin Balanced Infusion System

 

Diabetes

 

http://ClinicalTrials.gov/show/NCT01291719

 

 

 

Study 351 – Recruiting

 

A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)

 

Type 1 Diabetes

 

http://ClinicalTrials.gov/show/NCT01469715

 

 

 

Study 352 – Recruiting

 

GLP-1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Diabetic Patients With Aortocoronary Bypass

 

Type 2 Diabetes, Coronary Artery Disease

 

http://ClinicalTrials.gov/show/NCT01373216

 

 

 

Study 353 – Active, not recruiting

 

Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes

 

Metabolism and Nutrition Disorder, Obesity

 

http://ClinicalTrials.gov/show/NCT01272219

 

 

 

Study 354 – Active, not recruiting

 

Effects of Sitagliptin on Gastric Emptying in Healthy Subjects

 

Diabetic Gastroparesis

 

http://ClinicalTrials.gov/show/NCT00501657

 

 

 

Study 355 – Active, not recruiting

 

Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT00521937

 

 

 

Study 356 – Recruiting

 

Prevention of Cystic Fibrosis Diabetes

 

Cystic Fibrosis Diabetes

 

http://ClinicalTrials.gov/show/NCT00967798

 

 

 

Study 357 – Recruiting

 

A Study in Patients With Diabetic Kidney Disease

 

Diabetic Kidney Disease

 

http://ClinicalTrials.gov/show/NCT01113801

 

 

 

Study 358 – Active, not recruiting

 

Investigation of a Sub-Conjunctival Insert

 

Diabetes Care

 

http://ClinicalTrials.gov/show/NCT00999856

 

 

 

Study 359 – Recruiting

 

A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects

 

Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT00961025

 

 

 

Study 360 – Recruiting

 

Novel Therapies for Metabolic Complications of Lipodystrophies

 

Diabetes, Hypertriglyceridemia, Hepatic Steatosis

 

http://ClinicalTrials.gov/show/NCT00457938

 

 

 

Study 361 – Active, not recruiting

 

Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic

 

Diabetes, Dyslipidemia, Hypertension, Coronary Atherosclerosis

 

http://ClinicalTrials.gov/show/NCT00358033

 

 

 

Study 362 – Recruiting

 

Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes

 

Diabetic Peripheral Neuropathy

 

http://ClinicalTrials.gov/show/NCT00553592

 

 

 

Study 363 – Active, not recruiting

 

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS)

 

Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT01356849

 

 

 

Study 364 – Active, not recruiting

 

The READ-2 Study: Ranibizumab for Edema of the mAcula in Diabetes

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT00407381

 

 

 

Study 365 – Not yet recruiting

 

A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia

 

Diabetic Foot, Critical Limb Ischemia, Leg Ulcers

 

http://ClinicalTrials.gov/show/NCT00922389

 

 

 

Study 366 – Recruiting

 

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT00926068

 

 

 

Study 367 – Not yet recruiting

 

A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy

 

Diabetic Neuropathy

 

http://ClinicalTrials.gov/show/NCT01537705

 

 

 

Study 368 – Active, not recruiting

 

"Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT00665106

 

 

 

Study 369 – Recruiting

 

Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT01427569

 

 

 

Study 370 – Not yet recruiting

 

Safety Study of Topical Human FGF-1 for Wound Healing

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT00916292

 

 

 

Study 371 – Recruiting

 

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT01257815

 

 

 

Study 372 – Recruiting

 

Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

 

Diabetic Peripheral Neuropathy

 

http://ClinicalTrials.gov/show/NCT01496365

 

 

 

Study 373 – Recruiting

 

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)

 

Type 2 Diabetes, Acute Coronary Syndrome

 

http://ClinicalTrials.gov/show/NCT01147250

 

 


 

 

Study 374 – Recruiting

 

Efficacy and Safety Trial of Intravitreal Injections Combined With PRP for the Treatment of CSME Secondary to Diabetes Mellitus (DAVE)

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT01552408

 

 

 

Study 375 – Active, not recruiting

 

Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia

 

Hypertriglyceridemia, Dyslipidemia

 

http://ClinicalTrials.gov/show/NCT01211847

 

 

 

Study 376 – Active, not recruiting

 

Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral Neuropathy

 

Diabetic Polyneuropathy

 

http://ClinicalTrials.gov/show/NCT01175928

 

 

 

Study 377 – Recruiting

 

Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT01291160

 

 

 

Study 378 – Recruiting

 

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

 

Diabetic Kidney Disease

 

http://ClinicalTrials.gov/show/NCT01683409

 

 

 

Study 379 – Active, not recruiting

 

Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT00656643

 

 

 

Study 380 – Recruiting

 

Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy

 

Painful Diabetic Neuropathy

 

http://ClinicalTrials.gov/show/NCT01475786

 

 

 

Study 381 – Not yet recruiting

 

Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides

 

Hypertriglyceridemia

 

http://ClinicalTrials.gov/show/NCT00973271

 

 

 

Study 382 – Recruiting

 

A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients

 

Painful Diabetic Peripheral Neuropathy

 

http://ClinicalTrials.gov/show/NCT01478607

 

 

 

Study 383 – Recruiting

 

Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy

 

Diabetic Peripheral Neuropathy

 

http://ClinicalTrials.gov/show/NCT01504412

 

 

 

Study 384 – Recruiting

 

Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers

 

Chronic Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT00709514

 

 

 

Study 385 – Not yet recruiting

 

Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT01113515

 

 

 

Study 386 – Recruiting

 

Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain

 

Painful Diabetic Peripheral Neuropathy

 

http://ClinicalTrials.gov/show/NCT01455415

 

 

 

Study 387 – Recruiting

 

Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers

 

Diabetic Foot Ulcer

 

http://ClinicalTrials.gov/show/NCT01531517

 

 

 

Study 388 – Recruiting

 

Diabetic Peripheral Neuropathic Pain (DPNP)

 

Diabetic Peripheral Neuropathic Pain

 

http://ClinicalTrials.gov/show/NCT01314222

 

 

 

Study 389 – Active, not recruiting

 

The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy

 

Painful Diabetic Neuropathy

 

http://ClinicalTrials.gov/show/NCT00134524

 

 

 

Study 390 – Recruiting

 

A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)

 

Diabetic Peripheral Neuropathy

 

http://ClinicalTrials.gov/show/NCT01533428

 

 

 

Study 391 – Recruiting

 

A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy

 

Diabetic Neuropathic Pain

 

http://ClinicalTrials.gov/show/NCT01589432

 

 

 

Study 392 – Recruiting

 

A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT01070433

 

 

 

Study 393 – Recruiting

 

Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients

 

Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT01601236

 

 

 

Study 394 – Recruiting

 

Effects of PH3 in Diabetic Nephropathy

 

Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT01068041

 

 

 

Study 395 – Active, not recruiting

 

RLY5016 in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)

 

Diabetic Nephropathy, Hypertension, Hyperkalemia

 

http://ClinicalTrials.gov/show/NCT01371747

 

 

 

Study 396 – Recruiting

 

Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy

 

Painful Diabetic Neuropathy

 

http://ClinicalTrials.gov/show/NCT01332149

 

 

 

Study 397 – Not yet recruiting

 

A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)

 

Painful Diabetic Neuropathy

 

http://ClinicalTrials.gov/show/NCT01556152

 

 

 

Study 398 – Not yet recruiting

 

Bioburden Reduction of Diabetic Foot Ulcer

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT00776854

 

 

 

Study 399 – Not yet recruiting

 

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

 

Diabetic Foot Infections

 

http://ClinicalTrials.gov/show/NCT01590758

 

 

 

Study 400 – Recruiting

 

Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021 AM1)

 

Painful Diabetic Neuropathy

 

http://ClinicalTrials.gov/show/NCT01564459

 

 

 

Study 401 – Not yet recruiting

 

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

 

Diabetic Foot Infections

 

http://ClinicalTrials.gov/show/NCT01594762

 

 

 

Study 402 – Active, not recruiting

 

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study

 

Neuropathic Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT01217463

 

 

 

Study 403 – recruiting

 

Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)

 

Diabetic Peripheral Neuropathy

 

http://ClinicalTrials.gov/show/NCT01474772

 

 

 

Study 404 – Active, not recruiting

 

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study

 

Neuropathic Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT01217476

 

 

 

Study 405 – Recruiting

 

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

 

Diabetic Retinopathy

 

http://ClinicalTrials.gov/show/NCT00908778

 

 

 

Study 406 – Recruiting

 

A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT01490879

 

 

 

Study 407 – Active, not recruiting

 

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

 

Diabetic Nephropathy

 

http://ClinicalTrials.gov/show/NCT01399580

 

 

 

Study 408 – Not yet recruiting

 

Efficacy & Safety Study of Nonracemic Methadone for the Relief of Chronic Peripheral Neuropathic Pain

 

Diabetic Peripheral Neuropathic Pain

 

http://ClinicalTrials.gov/show/NCT01429181

 

 

 

Study 409 – Recruiting

 

A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

 

Diabetic Retinopathy

 

http://ClinicalTrials.gov/show/NCT01506895

 

 

 

Study 410 – Active, not recruiting

 

Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy

 

Diabetic Polyneuropathy

 

http://ClinicalTrials.gov/show/NCT00043797

 

 

 

Study 411 – Recruiting

 

Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept Study

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT01342497

 

 

 

Study 412 – Recruiting

 

A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy

 

Painful Diabetic Neuropathy

 

http://ClinicalTrials.gov/show/NCT01521598

 

 

 

Study 413 – Recruiting

 

Monochromatic Phototherapy on Diabetic Foot Ulcers

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT00859599

 

 

 

Study 414 – Recruiting

 

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT01445899

 

 

 

Study 415 – Recruiting

 

Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis

 

Nonalcoholic Steatohepatitis

 

http://ClinicalTrials.gov/show/NCT01237119

 

 

 

Study 416 – Recruiting

 

Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease

 

Chronic Kidney Disease

 

http://ClinicalTrials.gov/show/NCT01204528

 

 

 

Study 417 – Recruiting

 

Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy

 

Diabetic Peripheral Neuropathy

 

http://ClinicalTrials.gov/show/NCT01086150

 

 

 

Study 418 – Active, not recruiting

 

Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT00444600

 

 

 

Study 419 – Recruiting

 

A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)

 

Proliferative Diabetic Retinopathy

 

http://ClinicalTrials.gov/show/NCT01589029

 

 

 

Study 420 – Recruiting

 

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT01571232

 

 

 

Study 421 – Not yet recruiting

 

Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers

 

Diabetic Foot Ulcers

 

http://ClinicalTrials.gov/show/NCT01353937

 

 

 

Study 422 – Recruiting

 

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT01476449

 

 

 

Study 423 – Recruiting

 

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

 

Proliferative Diabetic Retinopathy

 

http://ClinicalTrials.gov/show/NCT00516464

 

 

 

Study 424 – Recrutiing

 

Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

 

Proliferative Diabetic Retinopathy

 

http://ClinicalTrials.gov/show/NCT01489189

 

 

 

Study 425 – Not yet recruiting

 

Blood Sugar Take Care and Glucose Metabolism

 

Prediabetes

 

http://ClinicalTrials.gov/show/NCT01554020

 

 

 

Study 426 – Recruiting

 

Gycabiane and Glycemic Control of Prediabetic Subjects

 

Prediabetes

 

http://ClinicalTrials.gov/show/NCT01530685

 

 

 

Study 427 – Recruiting

 

Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)

 

Obesity

 

http://ClinicalTrials.gov/show/NCT01601704

 

 

 

Study 428 – Recruiting

 

Diabetic Gastroparesis Efficacy/Safety Study of TZP-102

 

Diabetic Gastroparesis

 

http://ClinicalTrials.gov/show/NCT01664637

 

 

 

Study 429 – Recruiting

 

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT01135914

 

 

 

Study 430 – Active, not recruiting

 

Study to Assess the Effect of Cannabidiol on Liver Fat Levels in Subjects With Fatty Liver Disease.

 

Fatty Liver

 

http://ClinicalTrials.gov/show/NCT01284634

 

 

 

Study 431 – Recruiting

 

Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia

 

Type 1 Diabetes, Hypoglycemia

 

http://ClinicalTrials.gov/show/NCT01556594

 

 

 

Study 432 – Not yet recruiting

 

Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients

 

Type 1 Diabetes, Type 2 Diabetes

 

http://ClinicalTrials.gov/show/NCT01226537

 

 

 

Study 433 – Recruiting

 

Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis

 

Diabetic Gastroparesis

 

http://ClinicalTrials.gov/show/NCT01262898

 

 

 

Study 434 – Not yet recruiting

 

Treatment of Residual Diabetic Macular Edema With Ranibizumab

 

Diabetic Macular Edema

 

http://ClinicalTrials.gov/show/NCT01292798

 

 

 

Study 435 – Active, not recruiting

 

Evaluating Weight Loss Programs for Obese People at Risk for Heart Disease (The POWER Study)

 

Obesity

 

http://ClinicalTrials.gov/show/NCT00783315

 

 

 

Study 436 – Active, not recruiting

 

The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

 

Metabolic Syndrome X

 

http://ClinicalTrials.gov/show/NCT00400231

 

 

 

Study 437 – Recruiting

 

Effect of Sitagliptin on Graft Function Following Islet Transplantation

 

Islet Transplantation

 

http://ClinicalTrials.gov/show/NCT00853944

 

 

 

Study 438 – Active, not recruiting

 

Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis

 

Gastroparesis

 

http://ClinicalTrials.gov/show/NCT00432835

 

 

 

Study 439 -- Not yet recruiting

 

The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney Disease

 

Chronic Kidney Disease

 

http://ClinicalTrials.gov/show/NCT01000545

 

 

 

 

 

* Source: www.clinicaltrials.gov; Search criteria: Diabetes, Phase I, II, III; industry only.  Included are only active clinical trials -- active, not recruiting; recruiting, not yet recruiting, and enrolling by invitation. Search performed 10/24/2012.

 

More On PhRMA — powered by PhRMApedia